US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk
US regulators have strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Full Article
US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk
Zee News
0 shares
2 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Advertisement
More coverage
FDA restricts J&J’s Covid-19 vaccine due to blood clot risk
Indian Express
-
Covid-19 vaccine: US FDA limits use of Johnson and Johnson due to blood clot risk
DNA
-
FDA Further Limits Johnson & Johnson Covid Vaccine
NYTimes.com
-
FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot risk
USATODAY.com
-
FDA Drastically Reduces Use Of Johnson & Johnson Vaccine Over Blood Clots
Daily Caller